Company Filing History:

10 out of 1,384

Schering Aktiengesellschaft

patents

1 out of 1

Schring Aktiengesellschaft

patent

1 out of 192

Bayer Schering Pharma Ag

patents

Years Active: 1998-2009

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7601748 - Anti-androgenic pyrrolidines with tumor-inhibiting action (2009-10-13),

2. 7138421 - Anti-androgenic pyrrolidines with tumor-inhibiting action (2006-11-21),

3. 7074829 - Antiestrogens, process for their production and their pharmaceutical use (2006-07-11),

4. 6780855 - 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS (2004-08-24),

5. 6767903 - New7&agr;, 17&agr;-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases (2004-07-27),

6. 6559181 - Antiestrogens, process for their protection and their pharmaceutical use (2003-05-06),

7. 6288051 - 7 &agr;-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7 &agr;(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents (2001-09-11),

8. 6271403 - 7&agr;-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7&agr;-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents (2001-08-07),

9. 6166075 - Antiestrogens, process for their production and their pharmaceutical use (2000-12-26),

10. 5986115 - 7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, (1999-11-16),

11. 5866560 - 7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, (1999-02-02),

12. 5807899 - Triphenylethylenes, process for their production, pharmaceutical (1998-09-15),

Certainly! Here is the article about inventor Karsten Parczyk:

Title: Unveiling the Innovations of Karsten Parczyk in Berlin

Introduction:

Karsten Parczyk, a distinguished inventor based in Berlin, Germany, has made significant contributions to the field of pharmaceuticals with a total of 12 patents under his name. His groundbreaking work has revolutionized the landscape of anti-androgenic compounds with tumor-inhibiting properties.

Latest Patents:

Among his latest patents is the invention of Anti-androgenic pyrrolidines with tumor-inhibiting action. This breakthrough pertains to the development of anti-androgenic pyrrolidines that display a robust antiproliferative profile, offering new possibilities in the realm of cancer treatment. The patented formula I showcases his innovative approach towards pharmaceutical advancements.

Career Highlights:

Karsten Parczyk has harnessed his expertise while working at esteemed companies such as Schering Aktiengesellschaft and Bayer Schering Pharma AG. His tenure at these renowned institutions has been marked by a commitment to excellence and a passion for driving cutting-edge research in the pharmaceutical sector.

Collaborations:

Throughout his career, Karsten Parczyk has collaborated with notable professionals in the field, including visionary individuals like Rolf Bohlmann and Rosemarie Lichtner. These collaborations have fostered a culture of innovation, leading to the development of groundbreaking solutions that have the potential to transform the medical industry.

Conclusion:

In conclusion, Karsten Parczyk's relentless pursuit of innovation and his invaluable contributions to the field of pharmaceuticals have solidified his position as a trailblazer in the scientific community. His patents and inventions stand as a testament to his unwavering dedication to pushing the boundaries of what is possible in the realm of cancer treatment.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com